GlassScriptPhysician profile
Karen E Campos
NPI 1437806288
$5,975.79
in general payments reported to CMS, 2019-2025
26 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3,380 · 2023: $2,058 · 2024: $395 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,506 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,506.02 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,222.00 | 2022-2023 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $611.43 | 2022-2023 | Fasenra, Breztri, Symbicort |
| Actelion Pharmaceuticals US, INC. | $555.76 | 2022-2023 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $511.62 | 2022-2023 | Ofev, Stiolto Respimat |
| Galderma Laboratories, L.P. | $343.18 | 2024-2025 | Dysport |
| Regeneron Healthcare Solutions, INC. | $282.97 | 2022-2023 | Dupixent |
| Genzyme Corporation | $268.25 | 2022-2023 | |
| Mallinckrodt Hospital Products INC. | $260.54 | 2022-2023 | Acthar |
| United Therapeutics Corporation | $250.84 | 2022-2023 | Tyvaso |
| Mylan Specialty L.P. | $233.92 | 2022-2023 | Yupelri |
| Baxter Healthcare | $206.38 | 2022-2023 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Boston Scientific Corporation | $195.26 | 2024 | |
| Insmed, INC. | $177.12 | 2022-2023 | Arikayce |
| Takeda Pharmaceuticals U.S.A., INC. | $147.81 | 2022 | |
| Amgen INC. | $134.04 | 2022-2023 | Tezspire |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $105.13 | 2022-2023 | |
| Allergan, INC. | $99.79 | 2022 | |
| Grifols USA, LLC | $80.72 | 2022-2023 | Prolastin-C Liquid |
| Electromed, INC. | $70.04 | 2022-2023 | Smartvest |
| Novartis Pharmaceuticals Corporation | $45.00 | 2023 | |
| Philips North America LLC | $44.25 | 2022 | |
| Medtronic, INC. | $32.82 | 2023 | Illumisite |
| Pfizer INC. | $30.90 | 2022 | |
| Ani Pharmaceuticals, INC. | $28.43 | 2023 | Purified Cortrophin Gel |
| Inogen, INC. | $20.09 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Merck Sharp & Dohme LLC | $17.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Campos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.